Joan Merrill to Lupus Erythematosus, Cutaneous
This is a "connection" page, showing publications Joan Merrill has written about Lupus Erythematosus, Cutaneous.
Connection Strength
0.837
-
A double-blind, randomized, placebo-controlled, phase II trial of baricitinib for systemic lupus erythematosus: how to optimize lupus trials to examine effects on cutaneous lupus erythematosus. Br J Dermatol. 2019 05; 180(5):964-965.
Score: 0.658
-
Evaluating change in disease activity needed to reflect meaningful improvement in quality of life for clinical trials in cutaneous lupus erythematosus. J Am Acad Dermatol. 2021 Jun; 84(6):1562-1567.
Score: 0.179